IDYA · CIK 0001676725 · operating
IDEAYA Biosciences, Inc. (IDYA) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $2.9 billion, IDEAYA Biosciences, Inc. is a mid-cap company. The stock currently trades at $33.04, up 2.61% today, with a 52-week range of $13.45–$39.28.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.28 | $-1.28 | +61.9% | |
| 2024 | $-3.36 | $-3.36 | -71.4% | |
| 2023 | $-1.96 | $-1.96 | -38.0% | |
| 2022 | $-1.42 | $-1.42 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-17 | 0001193125-26-054533 | SEC ↗ |
| 2024-12-31 | 2025-02-18 | 0000950170-25-022183 | SEC ↗ |
| 2023-12-31 | 2024-02-20 | 0000950170-24-017093 | SEC ↗ |
| 2022-12-31 | 2023-03-07 | 0000950170-23-006456 | SEC ↗ |
| 2021-12-31 | 2022-03-18 | 0001564590-22-010922 | SEC ↗ |
| 2020-12-31 | 2021-03-23 | 0001564590-21-014676 | SEC ↗ |
| 2019-12-31 | 2020-03-24 | 0001564590-20-012501 | SEC ↗ |